glucocorticoids

Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial
Michael Bonelli, Helga Radner, Andreas Kerschbaumer, Daniel Mrak, Martina Durechova, Jutta Stieger, Rusmir Husic, Peter Mandl, Josef S Smolen, Christian Dejaco, Daniel Aletaha

Annals of the Rheumatic Diseases Jun 2022, 81 (6) 838-844; DOI: 10.1136/annrheumdis-2021-221126
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis
Lotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, Frank Buttgereit, Patrick Verschueren, Josef S Smolen, Robert BM Landewé, Johannes JW Bijlsma, Andreas Kerschbaumer, René Westhovens, Tom WJ Huizinga, Cornelia F Allaart, Sytske Anne Bergstra

Annals of the Rheumatic Diseases Apr 2022, annrheumdis-2022-222338; DOI: 10.1136/annrheumdis-2022-222338
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
Maria C Cid, Sebastian H Unizony, Daniel Blockmans, Elisabeth Brouwer, Lorenzo Dagna, Bhaskar Dasgupta, Bernhard Hellmich, Eamonn Molloy, Carlo Salvarani, Bruce C Trapnell, Kenneth J Warrington, Ian Wicks, Manoj Samant, Teresa Zhou, Lara Pupim, John F Paolini

Annals of the Rheumatic Diseases May 2022, 81 (5) 653-661; DOI: 10.1136/annrheumdis-2021-221865
Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection
Zhenyu Zhong, Weiting Liao, Lingyu Dai, Xiaojie Feng, Guannan Su, Yu Gao, Qiuying Wu, Peizeng Yang

Annals of the Rheumatic Diseases Apr 2022, 81 (4) 584-591; DOI: 10.1136/annrheumdis-2021-221650
Withdrawal of low-dose prednisone in inactive SLE patients: Is there another alternative?
José Mario Sabio

Annals of the Rheumatic Diseases Apr 2022, 81 (4) e57; DOI: 10.1136/annrheumdis-2020-217575
Response to: ‘Withdrawal of low-dose prednisone in inactive SLE patients: is there another alternative?’ by Sabio
Alexis Mathian, Micheline Pha, Zahir Amoura

Annals of the Rheumatic Diseases Apr 2022, 81 (4) e58; DOI: 10.1136/annrheumdis-2020-217641
Response to: ‘Glucocorticoid withdrawal in lupus: to do or not to do?’ by Acharya
Alexis Mathian, Micheline Pha, Zahir Amoura

Annals of the Rheumatic Diseases Mar 2022, 81 (3) e45; DOI: 10.1136/annrheumdis-2020-217282
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
Alessia Alunno, Aurélie Najm, Pedro M Machado, Heidi Bertheussen, Gerd-Rüdiger R Burmester, Francesco Carubbi, Gabriele De Marco, Roberto Giacomelli, Olivier Hermine, John D Isaacs, Isabelle Koné-Paut, César Magro-Checa, Iain B McInnes, Pier Luigi Meroni, Luca Quartuccio, A V Ramanan, Manuel Ramos-Casals, Javier Rodríguez Carrio, Hendrik Schulze-Koops, Tanja A Stamm, Sander W Tas, Benjamin Terrier, Dennis G McGonagle, Xavier Mariette

Annals of the Rheumatic Diseases Jan 2022, 81 (1) 34-40; DOI: 10.1136/annrheumdis-2021-221366
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis
Serena Bugatti, Ludovico De Stefano, Silvia Balduzzi, Maria Immacolata Greco, Terenzj Luvaro, Irene Cassaniti, Laura Bogliolo, Iolanda Mazzucchelli, Bernardo D’Onofrio, Michele di Lernia, Eleonora Mauric, Daniele Lilleri, Fausto Baldanti, Antonio Manzo, Carlomaurizio Montecucco

Annals of the Rheumatic Diseases Dec 2021, 80 (12) 1635-1638; DOI: 10.1136/annrheumdis-2021-220862
Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis
Anthony James Ocon, George Reed, Dimitrios A Pappas, Jeffrey R Curtis, Joel M Kremer

Annals of the Rheumatic Diseases Dec 2021, 80 (12) 1522-1529; DOI: 10.1136/annrheumdis-2021-220577

Main menu

glucocorticoids

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

glucocorticoids

Pages